You have 9 free searches left this month | for more free features.

City

Milano (1)

San Antonio (1)

Condition

Angiosarcoma (1)

Metastatic Microsatellite-stable Colorectal Cancer (1)

Mismatch Repair Protein Proficient (1)

Refractory Metastatic Colorectal Cancer (1)

Solid Tumor (1)

Urinary Bladder Neoplasms (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Agenus Inc. (1)

Rottapharm Biotech (1)

The University of Texas Health Science Center at San Antonio (1)

Collaborator

Agenus Inc. (1)

Intervention

agen2034 (3)

agen1884 (2)

cisplatin (1)

cr6086 (1)

gemcitabine (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

agen2034

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Angiosarcoma Trial (AGEN2034, AGEN1884)

Withdrawn

Angiosarcoma

AGEN2034
AGEN1884

(no location specified)

Dec 21, 2021

Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

Active, not recruiting

Urinary Bladder Neoplasms

AGEN1884
+3 more

San Antonio, Texas

Mays Cancer Center

Mar 11, 2022

Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer Trial in Milano

Recruiting

Refractory Metastatic Colorectal Cancer
+3 more

CR6086
AGEN2034

Milano, MI, Italy

Istituto Nazionale dei Tumori

Jan 24, 2022